Skip to main content
Transchem Limited. logo

Transchem Limited. — Investor Relations & Filings

Ticker · 500422 ISIN · INE019B01010 LEI · 3358002KFTC2CS9VDY51 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 359 across all filing types
Latest filing 2026-02-02 Regulatory Filings
Country IN India
Listing BSE.NS 500422

About Transchem Limited.

https://www.transchem.net/

Transchem Limited is a diversified enterprise primarily engaged in the cultivation, processing, and export of white button mushrooms. Operating through a specialized Export Oriented Unit, the company utilizes advanced technology for large-scale mushroom production, including climate-controlled growing rooms and automated processing lines. Its product portfolio features high-quality processed mushrooms available in various formats such as canned and frozen for international markets. In addition to its agribusiness operations, the company maintains a presence in the pharmaceutical sector, focusing on the manufacturing of bulk drugs and the trading of various chemical intermediates. The organization emphasizes quality control and adherence to international food safety standards to serve its global clientele.

Recent filings

Filing Released Lang Actions
Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results of ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange's listing compliance department, notifying about a scheduled Board Meeting to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. It references Regulation 29 of SEBI Listing Regulations, which pertains to prior intimation of board meetings. The document does not contain any financial data or results itself, but rather serves as a prior notice of the meeting where such results will be approved. The document length is short (2135 characters) and it is clearly an announcement of an upcoming event, not the report or results themselves. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and prior intimation under SEBI regulations, rather than an Interim Report (IR) or Earnings Release (ER).
2026-02-02 English
Please refer the attached intimation.
Regulatory Filings
2026-01-13 English
Please refer the attached intimation.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Listing Compliance Department of BSE Limited, informing about the closure of the trading window for insiders due to upcoming financial results. It references the company's Code of Conduct for Prevention of Insider Trading and SEBI regulations. The letter states that the trading window will be closed from January 1, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025. It also mentions that the date of the Board Meeting for the declaration of these results will be intimated separately. The document does not contain any financial data or results itself, nor does it present a report or detailed financial analysis. Instead, it is an announcement related to compliance and trading restrictions ahead of financial results. Given its nature as a regulatory compliance notification about trading restrictions and upcoming financial results, it fits best under Regulatory Filings (RNS). The document length is short (2140 characters), and it is clearly an announcement rather than a report or detailed filing.
2025-12-26 English
Please refer the attached intimation.
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to the Listing Compliance Department of BSE Limited, referencing a specific scrip code and ISIN. It informs about the alteration of the Memorandum of Association (MOA) specifically related to the increase in the Authorised Share Capital of the company, approved at an Extraordinary General Meeting. The content focuses on changes to the capital structure and the MOA clause, which is a capital change announcement. The document is short (3067 characters) and does not contain financial statements or detailed financial data, but rather an intimation of a corporate action regarding share capital. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2025-12-22 English
Please refer the attached intimation.
Regulatory Filings
2025-12-22 English
Please refer the attached intimation.
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed summary of the proceedings of the 2nd Extra-Ordinary General Meeting (EGM) of Transchem Limited for the financial year 2025-2026. It includes information about the meeting date, mode (video conferencing), attendees, quorum, voting procedures, and the business transacted, including resolutions passed. It is not a full financial report, audit report, or earnings release. It is not a notice or announcement of a report but a detailed record of the meeting proceedings. The content aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it summarizes the EGM proceedings and mentions that voting results will be declared soon. The document length (8427 characters) supports it being a substantive summary rather than a brief announcement. Therefore, the appropriate classification is DVA.
2025-12-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.